Published in Immunology on October 01, 1993
A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion. Infect Immun (1998) 1.02
A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. J Clin Invest (1995) 0.96
Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia. Infect Immun (1998) 0.96
Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun (1999) 0.88
The TNF Receptors p55 and p75 Mediate Chemotaxis of PMN Induced by TNFalpha and a TNFalpha 36-62 Peptide. Mediators Inflamm (1994) 0.75
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature (1985) 13.04
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods (1986) 8.88
Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 8.77
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol (1985) 7.20
Stimulation of neutrophils by tumor necrosis factor. J Immunol (1986) 5.72
Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature (1986) 4.81
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest (1987) 4.80
The cytokine network. Immunol Today (1989) 3.57
Structure of tumour necrosis factor. Nature (1989) 2.62
The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J Biol Chem (1989) 2.58
Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height. J Immunol Methods (1982) 2.57
Effect of tumour necrosis factor on cultured human melanoma cells. Nature (1975) 2.46
Letter: Polyamide supports for polypeptide synthesis. J Am Chem Soc (1975) 2.30
Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun (1986) 2.27
Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem (1989) 2.19
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol (1987) 1.81
The common mediator of shock, cachexia, and tumor necrosis. Adv Immunol (1988) 1.80
Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int Arch Allergy Appl Immunol (1988) 1.78
Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest (1988) 1.69
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects. J Immunol (1991) 1.51
Human neutrophils activated by interferon-gamma and tumour necrosis factor-alpha kill Entamoeba histolytica trophozoites in vitro. J Leukoc Biol (1989) 1.47
Neutrophil leukocyte emigration induced by endotoxin. Mediator roles of interleukin 1 and tumor necrosis factor alpha 1. J Immunol (1988) 1.39
Tumor necrosis factor alpha: a multifaceted peptide hormone. Crit Rev Immunol (1989) 1.32
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood (1988) 1.32
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun (1990) 1.28
Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol (1989) 1.17
Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments. Am J Physiol (1992) 1.10
Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha. Protein Eng (1990) 1.07
Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide. J Exp Med (1990) 0.98
Cloning and expression of human lymphotoxin mRNA derived from a human T cell hybridoma. J Biochem (1986) 0.92
Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody. Br J Cancer (1992) 0.89
Antigenic structure of human tumour necrosis factor: recognition of distinct regions of TNF alpha by different tumour cell receptors. Mol Immunol (1991) 0.87
Inhibition of tumour necrosis factor alpha (TNF-alpha)-induced neutrophil respiratory burst by a TNF inhibitor. Immunology (1991) 0.87
Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor. J Immunol (1988) 0.86
Comparative studies of the biological activities of human tumor necrosis factor and its derivatives. J Biochem (1987) 0.85
Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteins. J Biol Chem (1987) 0.83
Characterization of the major neutrophil-stimulating activity present in culture medium conditioned by Staphylococcus aureus-stimulated mononuclear leucocytes. Immunology (1991) 0.80
Studies of chemotactic, chemotactic movement-inhibiting and random movement-inhibiting effects of interleukin-1 alpha and beta, tumour necrosis factors alpha and beta and interferon gamma on human neutrophils in assays using 'sparse-pore' polycarbonate (Nuclepore) membranes in the Boyden chamber. Int Arch Allergy Appl Immunol (1990) 0.78
Tumor necrosis factor analogs: identification of functional domains. Anticancer Res (1990) 0.77
Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods (1980) 4.72
Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Infect Immun (1983) 3.85
Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol (1983) 3.85
Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun (1984) 3.47
A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods (1978) 3.18
Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height. J Immunol Methods (1982) 2.57
Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect Immun (1984) 2.12
Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol (1979) 1.93
Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin. Immunology (1986) 1.81
Early decay of human neutrophil chemotactic responsiveness following isolation from peripheral blood. Clin Exp Immunol (1980) 1.67
The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects. J Immunol (1991) 1.51
Adrenal cystic lesions: report of 12 surgically treated cases and review of the literature. J Endocrinol Invest (1998) 1.49
Autoimmune enteropathy with anti-goblet cell antibodies. Hum Pathol (1995) 1.47
Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri. Clin Exp Immunol (1984) 1.41
Children with hyperimmunoglobulinemia D and periodic fever syndrome. Pediatr Infect Dis J (1996) 1.40
Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass. Infect Immun (1997) 1.38
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem (1995) 1.38
The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery (1996) 1.33
Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth. J Immunol (1984) 1.32
Suppression of immunological responses in mice by treatment with amphotericin B. Clin Exp Immunol (1979) 1.30
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun (1990) 1.28
Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery (1997) 1.24
Alternative pathway activation of complement by African trypanosomes lacking a glycoprotein coat. Parasite Immunol (1983) 1.23
Bacterial resistance to uncouplers. J Bioenerg Biomembr (1994) 1.21
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect Immun (1992) 1.18
The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res (2001) 1.16
Conditioned medium from stimulated mononuclear leukocytes augments human neutrophil-mediated killing of a virulent Acanthamoeba sp. Infect Immun (1986) 1.14
IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. A possible parasite-immune evasion mechanism. J Immunol (1992) 1.13
Staphylococcus aureus-stimulated human mononuclear leucocyte-conditioned medium augments the basal and stimuli-induced neutrophil respiratory burst and degranulation. Immunology (1987) 1.13
Effect of tetracycline treatment on immunological responses in mice. Clin Exp Immunol (1980) 1.13
Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J Biol Chem (1995) 1.13
Primaquine inhibits mitogen-induced human lymphocyte proliferative responses. Trans R Soc Trop Med Hyg (1978) 1.12
Enhancement of base hexose-monophosphate shunt activity of human polymorphonuclear leucocytes by human beta-interferon. Immunol Lett (1984) 1.11
Role of myeloperoxidase in the killing of Naegleria fowleri by lymphokine-altered human neutrophils. Infect Immun (1987) 1.10
Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma. Immunology (1987) 1.10
Activation of complement by Naegleria. Trans R Soc Trop Med Hyg (1980) 1.09
Induced hypersensitivity to barbital in the female rat. Science (1967) 1.09
Immunization with live amoebae, amoebic lysate and culture supernatant in experimental Naegleria meningoencephalitis. Trans R Soc Trop Med Hyg (1980) 1.08
Amoebicidal activity of the antifungal antibiotic sinefungin against Entamoeba histolytica. Trans R Soc Trop Med Hyg (1984) 1.07
Antibody induced capping and endocytosis of surface antigens in Naegleria fowleri. Int J Parasitol (1979) 1.06
A semi-automated microassay technique for quantitative leukocyte iodination. J Immunol Methods (1978) 1.06
Effect of a boil water notice on behaviour in the management of a water contamination incident. Commun Dis Public Health (2000) 1.05
Site of expression of immunity to Naegleria fowleri in immunized mice. Parasite Immunol (1983) 1.05
Two outbreaks of Legionnaires' disease in Bolton Health District. Epidemiol Infect (1990) 1.05
Activation of the alternative pathway of complement by Acanthamoeba culbertsoni. Clin Exp Immunol (1983) 1.05
Alternative pathway of complement activation by Candida albicans. Aust N Z J Med (1978) 1.04
Latent hypersensitivity to pentobarbital in the rat. Proc Soc Exp Biol Med (1966) 1.04
Polyamine oxidase mediates intra-erythrocytic death of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1983) 1.04
Synthesis and surface expression of CD14 by human endothelial cells. Infect Immun (2001) 1.03
Effect of mefloquine on the immune response in mice. Trans R Soc Trop Med Hyg (1979) 1.03
Interleukin 2 inhibits migration and stimulates respiratory burst and degranulation of human neutrophils in vitro. Immunol Lett (1987) 1.01
Polyamine oxidase-mediated intraerythrocytic killing of Plasmodium falciparum: evidence against the role of reactive oxygen metabolites. Infect Immun (1984) 1.01
Simultaneous preparation of mononuclear and polymorphonuclear leucocytes from horse blood on Ficoll-Hypaque medium. J Immunol Methods (1980) 1.01
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome. Ann Rheum Dis (2003) 1.01
Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J Clin Invest (1992) 1.00
Macrophage-neutrophil interactions: contrasting effects of the monokines interleukin-1 and tumour necrosis factor (cachectin) on human neutrophil adherence. Immunology (1987) 0.99
Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses. J Infect Dis (1990) 0.99
Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils. J Immunol (1994) 0.99
Purification of human monocytes/macrophages by adherence to cytodex microcarriers. J Immunol Methods (1988) 0.99
Neutrophil phagocytic and bactericidal dysfunction induced by bilirubin. Aust Paediatr J (1977) 0.99
Increased lymphotoxin in human malarial serum, and the ability of this cytokine to increase plasma interleukin-6 and cause hypoglycaemia in mice: implications for malarial pathology. Trans R Soc Trop Med Hyg (1993) 0.98
The neutrophil respiratory burst. Responses to fatty acids, N-formylmethionylleucylphenylalanine and phorbol ester suggest divergent signalling mechanisms. Eur J Biochem (1991) 0.98
Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J (1990) 0.98
Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis. J Infect Dis (1999) 0.98
Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behav Brain Res (2012) 0.97
Role of the extracellular signal-regulated protein kinase cascade in human neutrophil killing of Staphylococcus aureus and Candida albicans and in migration. Infect Immun (1999) 0.97
A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. J Clin Invest (1995) 0.96
Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis. Med J Aust (1978) 0.96
Elevated natural killer (NK) cell activity: a possible role in resistance to infection and malignancy in immunodeficient splenectomized patients. Med Hypotheses (1985) 0.96
Changes in intestinal fluid and mucosal immune responses to cholera toxin in Giardia muris infection and binding of cholera toxin to Giardia muris trophozoites. Infect Immun (1985) 0.95
Abnormal neutrophil chemotaxis in a syndrome of unusual facies, proportionate small stature and sensorineural deafness-mutism. Acta Paediatr Scand (1978) 0.95
Neutrophil stimulation and priming by direct contact with activated human T lymphocytes. J Immunol (1992) 0.95
Polyamine oxidase-mediated trypanosome killing: the role of hydrogen peroxide and aldehydes. J Immunol (1984) 0.95
Protective immunity to Naegleria fowleri in experimental amebic meningoencephalitis. Am J Trop Med Hyg (1978) 0.95
In vitro sensitivity of virulent Acanthamoeba culbertsoni to a variety of drugs and antibiotics. Int J Parasitol (1984) 0.95
Polyamine oxidase-mediated killing of African trypanosomes. Parasite Immunol (1982) 0.95
Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid. Inhibition of tumor necrosis factor production. J Clin Invest (1997) 0.95
Activation of the alternative complement pathway by Torulopsis glabrata. Scand J Infect Dis (1979) 0.94
Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans. Sabouraudia (1979) 0.94
Immunopotentiation by pyrimethamine in the mouse. Clin Exp Immunol (1980) 0.94
Resistance of mice to Naegleria meningoencephalitis transferred by immune serum. Trans R Soc Trop Med Hyg (1978) 0.94
Stimulation of human neutrophil degranulation by mefloquine. Int Arch Allergy Appl Immunol (1988) 0.94
Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression. J Leukoc Biol (1993) 0.93
IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. Hum Immunol (1998) 0.93
Inhibition of the respiratory burst of human neutrophils by the polyamine oxidase-polyamine system. Int J Immunopharmacol (1986) 0.93
Effect of 22-32 carbon n-3 polyunsaturated fatty acids on superoxide production in human neutrophils: synergism of docosahexaenoic acid with f-met-leu-phe and phorbol ester. Immunology (1991) 0.93
Evidence implicating the mononuclear phagocytic system of the rat in immunity to infections with Trypanosoma lewisi. Aust J Exp Biol Med Sci (1978) 0.93
Surface immunoglobulins, a possible mechanism for the persistence of Trypanosoma lewisi in the circulation of rats. Aust J Exp Biol Med Sci (1977) 0.92
Depression of human polymorphonuclear leucocyte function by anti-malarial drugs. Immunology (1986) 0.92
Mitogenicity of Naegleria fowleri extract for murine T lymphocytes. Immunology (1984) 0.92
Direct evidence that ERK regulates the production/secretion of interleukin-2 in PHA/PMA-stimulated T lymphocytes. Immunology (1999) 0.92
Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry. Clin Diagn Lab Immunol (2000) 0.92
Activation of the phosphatidylinositol 3-kinase-Akt/protein kinase B signaling pathway in arachidonic acid-stimulated human myeloid and endothelial cells: involvement of the ErbB receptor family. J Biol Chem (2001) 0.91
Immune dysfunction in the presence of residual splenic tissue. Arch Dis Child (1982) 0.91
In vitro activation of rat brain protein kinase C by polyenoic very-long-chain fatty acids. J Neurochem (1994) 0.91
Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease. Clin Exp Rheumatol (2000) 0.91